Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1995 1
1997 1
1999 1
2000 1
2002 4
2003 4
2004 5
2005 4
2006 3
2007 2
2008 3
2009 3
2010 3
2011 1
2012 7
2013 8
2014 5
2015 8
2016 13
2017 8
2018 7
2019 14
2020 12
2021 13
2022 8
2023 9
2024 9

Text availability

Article attribute

Article type

Publication date

Search Results

141 results

Results by year

Filters applied: . Clear all
Page 1
Showing results for mathieu uz
Search for Mathieu Z instead (2 results)
Screening for Type 1 Diabetes in the General Population: A Status Report and Perspective.
Sims EK, Besser REJ, Dayan C, Geno Rasmussen C, Greenbaum C, Griffin KJ, Hagopian W, Knip M, Long AE, Martin F, Mathieu C, Rewers M, Steck AK, Wentworth JM, Rich SS, Kordonouri O, Ziegler AG, Herold KC; NIDDK Type 1 Diabetes TrialNet Study Group. Sims EK, et al. Diabetes. 2022 Apr 1;71(4):610-623. doi: 10.2337/dbi20-0054. Diabetes. 2022. PMID: 35316839 Free PMC article. Review.
Glycaemic management in diabetes: old and new approaches.
Ceriello A, Prattichizzo F, Phillip M, Hirsch IB, Mathieu C, Battelino T. Ceriello A, et al. Lancet Diabetes Endocrinol. 2022 Jan;10(1):75-84. doi: 10.1016/S2213-8587(21)00245-X. Epub 2021 Nov 15. Lancet Diabetes Endocrinol. 2022. PMID: 34793722 Review.
Conflict of Interest Disclosures.
[No authors listed] [No authors listed] Global Spine J. 2023 May;13(2_suppl):568S-591S. doi: 10.1177/21925682231173597. Global Spine J. 2023. PMID: 37222100 Free PMC article. No abstract available.
Efficacy and safety of co-administered once-weekly cagrilintide 2·4 mg with once-weekly semaglutide 2·4 mg in type 2 diabetes: a multicentre, randomised, double-blind, active-controlled, phase 2 trial.
Frias JP, Deenadayalan S, Erichsen L, Knop FK, Lingvay I, Macura S, Mathieu C, Pedersen SD, Davies M. Frias JP, et al. Lancet. 2023 Aug 26;402(10403):720-730. doi: 10.1016/S0140-6736(23)01163-7. Epub 2023 Jun 23. Lancet. 2023. PMID: 37364590 Clinical Trial.
International Consensus on Risk Management of Diabetic Ketoacidosis in Patients With Type 1 Diabetes Treated With Sodium-Glucose Cotransporter (SGLT) Inhibitors.
Danne T, Garg S, Peters AL, Buse JB, Mathieu C, Pettus JH, Alexander CM, Battelino T, Ampudia-Blasco FJ, Bode BW, Cariou B, Close KL, Dandona P, Dutta S, Ferrannini E, Fourlanos S, Grunberger G, Heller SR, Henry RR, Kurian MJ, Kushner JA, Oron T, Parkin CG, Pieber TR, Rodbard HW, Schatz D, Skyler JS, Tamborlane WV, Yokote K, Phillip M. Danne T, et al. Diabetes Care. 2019 Jun;42(6):1147-1154. doi: 10.2337/dc18-2316. Epub 2019 Feb 6. Diabetes Care. 2019. PMID: 30728224 Free PMC article. Review.
Incretins beyond type 2 diabetes.
Mathieu C, Ahmadzai I. Mathieu C, et al. Diabetologia. 2023 Oct;66(10):1809-1819. doi: 10.1007/s00125-023-05980-x. Epub 2023 Aug 8. Diabetologia. 2023. PMID: 37552238 Review.
Diabetic ketoacidosis.
Casteels K, Mathieu C. Casteels K, et al. Rev Endocr Metab Disord. 2003 May;4(2):159-66. doi: 10.1023/a:1022942120000. Rev Endocr Metab Disord. 2003. PMID: 12766544 Review. No abstract available.
141 results